Mutations in APP, PSEN1 and PSEN2 are responsible for the increase in Aβ-peptide production in patients and cause the same symptoms and cellular changes as described for sporadic AD (Finckh et al., 2005). This evidence concerns the gene APP and Alzheimer disease.